sábado, 19 de julio de 2025

Sarepta Therapeutics crisis is huge blow to Duchenne families, company Company has refused FDA request that it pull gene therapy from the market following patient deaths

https://www.statnews.com/2025/07/18/sarepta-therapeutics-duchenne-elevydis-fda-shipments-request/

No hay comentarios: